|
Exclusive Sales Agreement for H1N1 Virus Prevention Products
2009.10.29
|
|---|
|
Daehan New Pharm Signs Exclusive Contract to Sell “Vital Oxide,” a Disinfectant Registered with the U.S. EPA
KOSDAQ-listed Daehan New Pharm Co., Ltd. (CEO Bae Gun-woo) announced that it has signed an exclusive sales agreement for “Vital Oxide,” a sterilizing and disinfecting agent developed by U.S.-based Vital Technologies and registered with the U.S. Environmental Protection Agency (EPA).
As public concern over the H1N1 influenza virus continues to grow and the number of infections rises exponentially, clinical tests conducted by U.S. ATS Labs confirmed that Vital Oxide eliminates 99.9% of the H1N1 virus.
One of the key features of Vital Oxide is that it uses nano-technology to stabilize chlorine dioxide. Through oxidation by oxygen atoms in the chlorine dioxide, the product achieves 99.9% sterilization against Gram-positive and Gram-negative bacteria, including Staphylococcus aureus and E. coli. The disinfecting efficacy of the product has been verified through sterilization testing conducted by the Korea Testing & Research Institute (KTR).
Unlike most conventional hand sanitizers that rely on alcohol and are only effective for bacterial removal, Vital Oxide also provides sterilization against bacteria and the H1N1 virus. Moreover, it has been certified by the National Sanitation Foundation (NSF) as a food-surface sanitizer, reflecting its extremely low toxicity and high level of safety.
Daehan New Pharm plans to introduce Vital Oxide next month as a multipurpose product designed for hand sanitization and H1N1 infection prevention. |


Home